2026 Best Abstract Award Nominees

2026 ABSTRACT INFORMATION

ABSTRACT NOMINEES

BEST ABSTRACT AWARD NOMINEES BY STUDENT +
Moiz Lakhani, BHSc

Ischemic Optic Neuropathy Associated with Semaglutide: Global Population-Based Analysis of Over 30 Million Safety Reports

Drenushe Krasniqi-Vanmeter, BA

3D Imaging and Filament Tracing of Human Orbital Vasculature and Lymphatic System

Eden Terera

Characterizing 18F-FDG Uptake in Extraocular Muscles of Patients with Parkinson’s Disease

Jainam Shah, BS

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in GLP-1 Agonist Users and Associated Social Determinants of Health in the NIH All of Us Research Program

Mickey Nguyen

Features of Transient Vision Loss: A Study of 300 Patients

Sofia John, BA

Investigating Regional Cerebrospinal Fluid Flow Alterations in Patients Diagnosed with Idiopathic Intracranial Hypertension

Kathryn Huang

Temporal Trends in Optic Pathway Glioma Survival: A Population-Based Analysis

BEST ABSTRACT AWARD NOMINEES BY RESIDENT +
David Szanto,BA

Optic Disc Drusen Association to NAION

Michael Stormly Hansen MD, FEBO

Ultrasound, PET/CT, or Temporal Artery Biopsy for Giant Cell Arteritis? A Prospective Diagnostic Accuracy Study (the GAME-study)

Madhura Shah BS, MD

Risk of Sequential Non-Arteritic Anterior Ischemic Optic Neuropathy

Rahul Dhodapkar

StrabScan: interpretable biometrics-based machine learning for automated quantification of horizontal manifest deviations in pediatric strabismus

Jae Ryong Song MD

Normative Percentiles and Age-Related Change Points for RNFL and GCIPL Thickness in Healthy Adults based on Cirrus HD-OCT

Francesco Cutrupi MD

Neurovascular Compression Between the Supraclinoid Internal Carotid Artery and Anterior Optic Pathway: Establishing Clinical and MRI Diagnostic Criteria

Anthony Cordisco MD, MA, BS

Association between disease-modifying therapies for multiple sclerosis and risk of non-infectious uveitis

Sydney Chatfield

Utilizing Inter-Eye RNFL Thickness Difference via OCT for Detecting Remote Optic Neuritis In Pediatric-Onset Multiple Sclerosis: Validation of a 4 µm Threshold

JAMES A. SHARPE BEST ABSTRACT NOMINEES BY A FELLOW-IN-TRAINING +
Stephanie Syc-Mazurek

Frequency of optic nerve enhancement during acute optic neuritis in MOG antibody-associated disease

Ming Yang MD, PhD

Targeting Lipid Peroxidation As A Treatment For NAION

Maryam Golmohammadi MD

Deep Learning-Based Retinal Vessel Segmentation and Analysis of Intensity and Density in Leber’s Hereditary Optic Neuropathy

Leonardo Ariello M.D,

Vestibulo-Ocular Reflex Gain Differentiates Spinocerebellar Ataxia Type 27B from CANVAS and Idiopathic Late-Onset Cerebellar Ataxia

Madhuri Akella MD

EyeStroke protocol with non-mydriatic color fundus photography and optical coherence tomography (NMFP-OCT) in the emergency department (ED): 2.5-year experience

Anas Alkhabaz MBBS

Optic Nerve Calcification and Altered Plasma Lipidomics in Non-Arteritic Anterior Ischemic Optic Neuropathy

ABSTRACT SUBMISSION INFORMATION +

The NANOS abstract submission portal is closed.

Walsh Cases

Those who submitted Walsh submissions that were not accepted for presentation were given the opportunity to resubmit as a Descriptive Studies poster if they were rated above the Walsh committee's mean score.(Process now complete)

  • Only one submission per first/presenting author is allowed per abstract category.
Analytical and Descriptive Study Guidelines

In 2026 there will be no e-poster submissions, only printed posters.

Reasons Your Abstract Can Be Rejected

While NANOS strives to accept all abstracts that are of adequate scientific quality and in particular to support the presentation of abstracts by trainees, several reasons can result in your abstract being rejected. These include but are not limited to

  • No data presented, only plans (except, e.g., when the purpose is to present the design of a complex study). The abstract committee strongly suggests that even trainees who may have had limited time in their programs before the abstract deadline to include some data in their results, e.g., the expected number of charts to be reviewed, interim results, etc. In some cases, the abstract committee may permit authors to resubmit more developed abstracts before the deadlines for producing the syllabus.
  • No or unclear relationship to neuro-ophthalmology
  • Poorly written English that makes the abstract unable to be understood
  • Clear commercial bias (e.g., advertising)
  • Failure to follow submission instructions, formatting, etc.
NANOS Trainee Award Criteria

The NANOS Abstract Committee aims to promote the work of supervised medical students, residents, and fellows-in- training who represent the future of neuro-ophthalmology. Due to the wide variety of structures for training programs, especially internationally, the positions of all trainees nominated for awards will be reviewed to ensure they are reasonably equivalent to the relevant award category and ensure a fair competition. This review will be undertaken by one or more members assigned by the NANOS board who are familiar with international training programs.

The decisions regarding the award eligibility of this group in coordination with the Abstract Committee will be considered final. Awards for the best work performed and presented by a supervised student (eligible students are current medical students - MD, DO - or students in a doctoral program - PhD or equivalent - who have not already completed a medical degree), resident, and fellow-in-training are available.

Trainees must be in training at the time of submission. To be eligible for consideration for these trainee awards, the presenting author must be in a training program leading to a degree or medical certification at the time of abstract submission and their nomination must be supported by their supervisor. Individuals applying for trainee awards are responsible for ensuring that they meet the appropriate eligibility criteria and provide the necessary information with which to verify this during the abstract submission process. This will be verified prior to award distribution. Due to the wide variety of structures for training programs, especially internationally, the positions of all trainees nominated for awards will be reviewed to ensure they are reasonably equivalent to the relevant award category and ensure a fair competition. This review will be undertaken by one or more members assigned by the NANOS board who are familiar with international training programs. The decisions regarding award eligibility of this group in coordination with the Abstract Committee will be considered final.

REMINDER!

All platform/Walsh acceptances are subject to CME approval and no employees of ineligible companies* can present.

* Ineligible companies: companies that are ineligible to be accredited in the ACCME System (now known as ineligible companies) are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Examples of such organizations include:
  • Advertising, marketing, or communication firms whose clients are ineligible companies
  • Bio-medical startups that have begun a governmental regulatory approval process
  • Compounding pharmacies that manufacture proprietary compounds
  • Device manufacturers or distributors
  • Diagnostic labs that sell proprietary products
  • Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
  • Manufacturers of health-related wearable products
  • Pharmaceutical companies or distributors
  • Pharmacy benefit managers
  • Reagent manufacturers or sellers

Award Winners for the Walsh & Abstracts will be announced on Monday night (March 23, 2026).

If you have a question about your submission please contact meetings@nanosweb.org

Search Link